Protecting America’s Medical Supply Chains Act of 2026
Sponsored By: Representative Salazar
Introduced
Summary
This bill would strengthen and secure U.S. medical supply chains by expanding the Defense Production Act (DPA) to explicitly cover drugs, medical devices, and biological products. It would require a White House strategy, annual progress reports, and authorize targeted payments to U.S.-based producers to reduce foreign dependencies and protect national defense supplies.
Show full summary
- Domestic medical manufacturers would be eligible for targeted payments under DPA Section 303(h) if they are organized under U.S. law and produce critical components, technology, or raw materials. Payments must be preceded by a certification to Congress at least 30 days before disbursement.
- The President would have 180 days to send Congress a strategy that analyzes supply chain vulnerabilities, recommends diversification measures, and sets timelines to avoid exclusive foreign control of essential components. Annual progress reports would run through Sept. 30, 2029 and may include an unclassified report with a classified annex.
- The DPA's definition of "materials" would explicitly include "medical materials" such as drugs, devices, and biological products as essential to national defense. The President would issue regulations within 90 days to define "supply chain" and related activities for these efforts.
Personalized for You
How does this bill affect your finances?
Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Bill Overview
Analyzed Economic Effects
2 provisions identified: 2 benefits, 0 costs, 0 mixed.
Prioritize medical supplies under DPA
This bill would expand the Defense Production Act to treat medical materials as "essential materials." That includes drugs (under the Food, Drug, and Cosmetic Act), devices, and biological products (under the Public Health Service Act) used to diagnose, treat, or prevent disease. The bill would direct the government to use DPA authorities, when appropriate, to help keep these medical supplies available and to include measures to secure the drug supply chain. Implementation would have to take into account U.S. competitiveness, scientific leadership, cooperation, and innovative capacity.
Government payments to U.S. supply firms
This bill would let the President make payments to U.S.-organized firms to strengthen supply chains. The President would have to certify to Congress at least 30 days before a payment that the payment is critical to meet national defense needs. Eligible firms would be U.S.-organized and make critical components, technology, or raw materials used for supply chain security. The President would have to issue regulations within 90 days to define "supply chain" and "supply chain activities," including organizations, people, activities, information, and resources for government-used products and critical infrastructure.
Sponsors & CoSponsors
Sponsor
Salazar
FL • R
Cosponsors
There are no cosponsors for this bill.
Roll Call Votes
No roll call votes available for this bill.
View on Congress.gov